Skin appendageal immune reactivity in a case of cutaneous lupus by Ana Maria Abreu Velez et al.
  175 
 
 
 
SKIN APPENDAGEAL IMMUNE REACTIVITY IN A CASE 
OF CUTANEOUS LUPUS  
REAKTYWNOŚĆ IMMUNOLOGICZNA PRZYDATKÓW SKÓRY NA 
PRZYKŁADZIE PRZYPADKU SKÓRNEJ POSTACI TOCZNIA 
 
Ana Maria Abreu Velez
1, A. Deo Klein
2, Michael S. Howard
1 
 
1Georgia Dermatopathology Associates, Atlanta, Georgia, USA. 
2Statesboro Dermatology, Statesboro, Georgia, USA  
Corresponding author: Ana Maria Abreu-Velez, MD PhD  abreuvelez@yahoo.com
 
  
Our Dermatol Online. 2011; 2(4): 175-180                               Date of submission: 17.04.2011 / acceptance: 25.07.2011 
                                                                                                                                            Conflicts of interest: None 
 
 
Abstract 
Background: Discoid lupus erythematosus is a cutaneous disease with a worldwide distribution, and its pathogenesis remains unclear. 
Case Report: A 41 year old male was evaluated for hair loss, in patches on the scalp. We studied selected adaptor proteins expressed in 
T, natural killer, neutrophil and mast cells; these proteins are important mediators for antigen receptor signaling in situ. Methods: Skin 
biopsies for hematoxylin and eosin examination, as well as for direct immunofluorescence and immunohistochemistry analysis were 
performed.  Results:  Hematoxylin  and  eosin  staining  demonstrated  classic  features  of  lupus  with  focal  dermal  scarring;  epidermal 
atrophy was noted, with lymphohistiocytic infiltrates around the skin appendages. Direct immunofluoresence revealed classic, lupus band 
positive staining along the dermal/epidermal junction. In addition, immune reactants were identified in neurovascular areas, and around 
pilosebaceous units. Immunohistochemistry staining showed positive staining for the T-cell antigen receptor zeta chain, the linker for 
activation of T cells, myeloperoxidase, cyclo-oxygenase 2, melanoma-associated antigen 1, B cell leukemia/lymphoma-2 associated X 
protein, and BCL-2 markers. The positive staining was observed within the dermal inflammatory infiltrate, around pilosebaceous units, 
upper dermal blood vessels, and focally within eccrine sweat glands. Conclusions: The pathobiology of cutaneous lupus involves not 
only the epidermis, but also dermal pilosebaceous units, eccrine sweat glands and blood vessels. Further studies are recommended, 
especially in the light of presented data regarding T cell activation and proapototic molecules. 
 
Streszczenie 
Wstęp:  Dyskoidalny  toczeń  rumieniowaty  jest  chorobą  skóry z dystrybucją na całym świecie, a jej patogeneza jest niejasna. Opis 
przypadku: 41-letni męŜczyzna został diagnozowany z powodu wypadania włosów na skórze głowy. Badano ekspresje selektywnego 
adaptera  białek  na  limfocytach  T,  komórkach-natural  killer,  neutrofilach i komórkach tucznych; białka te są waŜnymi mediatorami 
receptora  antygenu  sygnalizacji  in  situ.  Metody:  Wykonano  biopsję  skóry  w  barwieniu  hematoksyliną  i  eozyną,  jak  równieŜ  
immunofluorescencję bezpośrednią i analizę immunohistochemiczną. Wyniki: Barwienie hematoksyliną i eozyną wykazały klasyczne 
cechy tocznia z ogniskową blizną skóry; obserwowano zanik naskórka z lymphohistiocytarnymi naciekami w obrębie przydatków skóry. 
Immunofluorescencja bezpośrednia wykazała klasyczne, lupus band pozytywne barwienie wzdłuŜ połączenia skóra / naskórek. Ponadto, 
immunologiczne  reagenty  zostały  zidentyfikowane w obszarach naczyniowych i w okolicy jednostek włosowo-łojowych. Barwienia 
immunohistochemiczne wykazały pozytywne barwienie dla antygenu T-cell receptor łańcucha zeta, łącznika do aktywacji limfocytów T, 
MPO, cyklooksygenazy 2, antygenu związanego z czerniakiem 1, komórek B leukemia/lymphoma-2 związanych z białkiem X i BCL- 2 
markera.  Pozytywne  barwienie  stwierdzono  w  nacieku  zapalnym  skóry,  w  obrębie  jednostek  włosowo-łojowych,  górnych  naczyń 
krwionośnych skóry i ogniskowo w ekrynowych gruczołach potowych. Wnioski: Patobiologia skórnej postaci tocznia nie dotyczy tylko 
naskórka, ale równieŜ skórnych jednostek włosowo-łojowych, ekrynowych gruczołów potowych i naczyń krwionośnych. Niezbędne są 
dalsze badania, zwłaszcza w świetle przedstawionych danych dotyczących aktywacji komórek T i proapototycznych cząsteczek. 
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Introduction 
Cutaneous  lupus  erythematosus  (LE)  covers  a 
broad morphological spectrum, extending beyond acute, 
subacute  and  chronic  cutaneous  lupus  erythematosus, 
which  are  commonly  classified  as  lupus-specific  skin 
disease  [1].  Other,  less  common  presentrations  include 
tumid  lupus  erythematosus,  lupus  profundus,  chilblain 
lupus,  mucosal  lupus  erythematosus  and  bullous  lupus 
erythematosus  [1].  Possible  vascular  sequelae  of  lupus 
erythematosus  include  leukocytoclasis,  urticarial 
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vasculitis,  livedoid  vasculopathy  and  livedo  reticularis 
[1].  Many  previous  histologic  investigations  have 
emphasized 1) immune deposits at the dermoepidermal 
junction (DEJ) of the base membrane zone (BMZ), i.e., 
the lupus band), and 2) the role of autoantibodies and 
antibody  dependent  cellular  cytotoxicity  in  the 
pathogenesis of LE [1]. It is known that autoimmune T 
helper cells drive pathogenic autoantibody production in 
LE, but the mechanisms maintaining those pathogenic T 
cells  are  unknown.  Here,  we  explore  pertinent  T  cell 
signaling  activators,  and  the  possible  roles  of  other 
immune  cells  mediators  in  lupus  erythematosus.  We 
include products derived from activated neutrophils, such 
myeloperoxidase; and also other molecules located in a 
lupus  susceptibility  region  on  chromosome  1,  such  as 
cyclo-oxygenase 2. 
 
Case report 
A  41  year  old  male  was  evaluated  for  the 
presence of hair loss, in patches in the scalp. On physical 
exam,  the  patient  demonstrated  atrophic  scaly  scalp 
plaques, with hair loss inside the plaques. A lesional skin 
biopsy  was  taken  for  hematoxylin  and  eosin  (H&E) 
analysis.  In  addition,  direct  immunofluorescence  (DIF) 
and  immunohistochemistry  (IHC)  studies  were 
performed. 
 
Methods 
In  brief,  skin  preparations  for  H&E,  DIF  and 
IHC studies were performed as previously described. We 
utilized  antibodies  from  Dako  (Carpinteria,  California 
USA),  including  1)  anti-human  cyclo-oxygenase  2 
antibody (COX-2), which does not crossreact with cyclo-
oxygenase  1,  2)  the  T-cell  antigen  receptor  zeta  chain 
(ZAP-70 antibody), 3) the linker for activation of T cells 
(LAT),  myeloperoxidase,  4)  mutated  melanoma-
associated  antigen  1  (MUM-1),  5)    B  cell 
leukemia/lymphoma-2 associated X protein (BAX) and 
6)  BCL-2  antibody.  The  direct  immunofluorescence 
(DIF)  and  immunohistochemistry  (IHC)  studies 
performed as previously described [2-10].  
 
 
Results 
Microscopic description: 
Examination  of  the  H&E  tissue  sections 
demonstrated  classic  features  of  lupus  erythematosus; 
focal atrophy and follicular plugging were noted within 
the  epidermis.  The  presence  of  a  mild,  perifollicular 
concentric fibrosis and in few areas with some scarring 
was  seen.  No  significant  interface  inflammation  was 
noted.  A  mild,  superficial  and  deep,  perivascular  and 
periadnexal  dermal  infiltrate  of  lymphocytes, 
lymphocytes, plasmacytoid lymphocytes and histiocytes 
was noted. Neutrophils and eosinophils were rare. Mild, 
perifollicular  concentric  fibrosis  was  observed,  with 
additional  areas  of  interstitial  scarring.  The  Verhoeff 
elastin  special  stain  confirmed  the  extent  of  dermal 
scarring  (Fig.  1,2).  Focal  edema  was  also  appreciated 
around  sebaceous  and  eccrine  sweat  glands.  DIF 
demonstrated  the  following  staining  results:  IgG  (++, 
focal  and  linear  at  the  epidermal  basement  membrane 
zone (BMZ), sebaceous gland BMZs and within selected 
neurovascular  structures; IgA (-); IgM (+, focal, linear 
epidermal  BMZ  and  dermal  perivascular);  IgE  (+,  in 
selected  papillary  dermal  cells;  Complement/C1q  (++, 
focal and linear at epidermal BMZ and sebaceous gland 
BMZs);  Complement/C3  (++,  focal  linear  epidermal 
BMZ and sebaceous gland BMZs, and surrounding some 
dermal  neurovascular  structures;  Complement/C4  (++, 
focal  perifollicular  and  surrounding  dermal 
neurovascular  structures);  Kappa  and  Lambda  light 
chains  (+,  focal  punctate  epidermal  BMZ,  and 
surrounding  dermal  neurovascular  structures  and  sweat 
glands); Albumin (++, focal linear epidermal BMZ and 
sebaceous  gland  BMZs);  fibrinogen  (++,  focal  linear 
epidermal  BMZ  and  sebaceous  gland  BMZs)  and, 
finally, ZAP-70, LAT, myeloperoxidase, COX-2, MUM-
1, and BCL-2 (+), around dermal sebaceous and sweat 
glands, and dermal blood vessels (Fig. 1,2). In addition, 
some  of  these  final  antibodies  clearly reacted with the 
BMZs of the sebaceous and sweat glands. 
 
Discussion 
  Consistent  histopathologic  features  in  many 
cutaneous  lesions  of  LE  include  a  perivascular 
mononuclear cell infiltrate, with subsequent involvement 
of the epidermis and dermal appendages. The histologic 
alterations affecting the epidermis, dermis, and adnexal 
structures  reflect  the  specific  lesion  biopsied,  and 
lesional age at the time of biopsy [11,12]. The multiple 
clinical  and  serologic  forms  of  lupus  erythematosus 
cannot  reliably  be  distinguished  histologically,  which 
supports  the  premise  that  lupus  erythematosus  is  a 
disease  presenting  a  wide  spectrum  of  clinical 
manifestations  and  a  common  underlying  pathogenesis 
[11,1 2].  
In our case, we were able to observe how skin adnexal 
structures and dermal blood vessels interfaced with the 
pathologic  inflammatory  infiltrate;  specifically,  T  cells 
and  neutrophil  activated,  downstream  cell  signaling 
molecules  seem  to  play  significant  roles  in  the 
pathophysiology.  Most  of  the  markers  of  immune 
activation were identified in the adnexal structures. We 
were  able  to  identify  the  presence  of  COX-2,  an 
inducible enzyme that is normally absent in skin cells; 
however, in response to growth factors, tumor promoters 
and  some  cytokines,  it  exhibits  a  rapid  and  transient 
expression.  In  addition,  ZAP-70  plays  a  role  in 
lymphocyte activation.  It is known that autoimmune T 
helper cells drive pathogenic autoantibody production in 
systemic  lupus  erythematosus  (SLE);  however,  the 
pathologic  mechanisms  maintaining  these  T  cells  are 
unknown.  Here  we  demonstrated  both  TCR  (T-cell 
antigen  receptor)  mediated  and  pre-TCR  mediated 
signaling, both in developing and mature T lymphocytes. 
LAT is involved in FcGR3 (low affinity immunoglobulin 
gamma  Fc  region  receptor  III)-mediated  signaling  in 
natural  killer  cells,  as  well  as  FcER1  (high  affinity 
immunoglobulin epsilon receptor)-mediated signaling in 
mast  cells.  Coupled  activation  of  these  receptors  and 
their associated kinases would then result in downstream 
intracellular  events,  including  mobilization  of 
intracellular  calcium  stores,  PKC  activation,  MAPK 
activation and/or cytoskeletal reorganization through the 
recruitment  of  PLCG1,  GRB2,  GRAP2,  and  other 
signaling molecules. 
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Figure  1.  a.  H&E,  showing  atrophy  of  the  epidermis,  follicular  plugging  and  no  significant  hyperkeratosis  Mild, 
perifollicular concentric fibrosis is present, with additional focal interstitial scarring. A mild, superficial, perivascular and 
periadnexal dermal inflammatory infiltrate is also noted. Focal edema is present within the dermis, especially around hair 
follicular units (blue arrow). b. Positive staining within a hair follicle with the MUM-1 antibody (brown staining; red 
arrow). c. Positive staining with LAT antibody on an upper dermal perivascular infiltrate (brown staining; blue arrows).  
d. Positive staining with anti-BAX antibody accentuated at the basement membrane zone (BMZ) of the epidermis, as well 
as on individual cells within the papillary dermis(brown staining; red arrows). e. Positive staining with FITC conjugated 
anti-human-Complement/C3 against the BMZ of the epidermis (green staining; red arrow) and against upper dermal blood 
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vessels (green staining; yellow arrow). f. Positive staining with FITC conjugated anti-human-complement/C3 against the 
BMZ of a sebaceous glands and some areas within the gland (green staining; red arrows). g. IHC positive staining of a hair 
follicle with complement/C3, at the BMZ of the hair follicle and inside the hair follicle (brown staining; red arrows).  
h. Complement/C1q positive IHC staining inside the hair follicle shaft and at the epidermal BMZ area (brown staining; red 
arrows). i, COX-2 positive staining at the BMZ of a hair follicular unit and in a perifollicular inflammatory infiltrate(dark 
staining; red arrows). j. IHC positive staining with BCL-2 on inflammatory cells around sebaceous glands (dark staining; 
maroon arrows). k. IHC positive staining with ZAP-70 inside an eccrine gland coil (dark staining; maroon arrows). l. DIF 
positive staining against eccrine sweat glands using FITC conjugated anti-human IgG (green staining; yellow arrows). 
 
 
 
Autoreactive T cells are normally eliminated by 
1)  functional  inactivation  (anergy)  and  2)  activation-
induced  cell  death  (AICD;  directed  apoptosis)  through 
death  receptor  (Fas)  signaling.  Other  authors  have 
reported  that  activated  T  cells  of  lupus  patients  resist 
anergy  and  apoptosis  by  markedly  upregulating  and 
sustaining COX-2 expression [13]. Inhibition of COX-2 
caused apoptosis of the anergy-resistant lupus T cells by 
augmenting  Fas  signaling  and  markedly  decreasing the 
survival  molecule  c-FLIP  (cellular  homolog  of  viral 
FLICE  inhibitory  protein)  [13].    Studies  with  COX-2 
inhibitors and COX-2 deficient mice confirmed that this 
COX-2/FLIP  antiapoptosis  program  has  been  used 
selectively by anergy-resistant lupus T cells, and not by 
cancer cells or other autoimmune T cells [13]. Notably, 
the  gene  encoding  COX-2  is  located  in  a  lupus-
susceptibility  region  on  chromosome  1.  The  same 
authors also found that selected COX-2 inhibitors were 
able  to  suppress  the  production  of  pathogenic 
autoantibodies  to  DNA  by  causing  autoimmune  T-cell 
apoptosis,  an  effect  that  was  independent  of 
prostaglandin E2 (PGE2) [13]. These findings could be 
useful in the design of lupus therapies. Our COX-2 data 
is  consistent  with  expression  of  this  molecule  in  the 
context of clinical lupus erythematosus. 
The ZAP-70 gene encodes an enzyme belonging to the 
tyrosine  kinase  protein  family;  ZAP-70  plays  roles  in 
both T lymphocyte development and activation [14]. The 
ZAP-70 enzyme, which is phosphorylated on its tyrosine 
residues upon T cell antigen receptor (TCR) stimulation, 
functions  in  the  initial  step  of  TCR-mediated  signal 
transduction  in  combination  with  Src  family  kinases. 
Mutations in the ZAP-70 gene result in a form of severe 
combined  immunodeficiency  (SCID)  syndrome  in 
humans  [14].  ZAP-70  expression  is  also  found  in  a 
subset  of  chronic  lymphocytic  leukemia  patients  with 
unmutated Ig genes and a poor clinical course [14]. LAT, 
a  transmembrane  adaptor  protein  expressed  in  T 
lymphocytes, natural killer cells and mast cells, is also an 
important mediator for TCR signaling [14]. Upon TCR 
engagement,  activated  ZAP-70  phosphorylates  LAT  at 
multiple conserved tyrosine residues within SH2 binding 
motifs,  exposing  these  motifs  as  the  docking  sites  for 
downstream signaling targets [14].  The phosphorylation 
process  in  LAT  eventually  leads  to  activation  of  the 
corresponding signaling pathways [14].  
In  regard  to  the  positive  staining  for  BAX,  the  BAX 
protein is a pro-apoptotic member of the Bcl-2 family of 
proteins; BAX is found in many cell types [15]. Bax is a 
cytosolic  protein  that  translocates  to  the  mitochondria 
and participates in Cytochrome c release in response to 
apoptotic  stimuli  [15].  Aberrant  expression  of  BCL-2 
family members can inappropriately promote or prevent 
apoptosis.  Increased  expression  of  BAX  is  associated 
with the apoptotic loss of neurons in Parkinson's disease 
[15].  Given  1)  the  presence  of  junctional  zone  cytoid 
bodies  in  many  cases  of  LE  and  2)  our  BAX  IHC 
findings, the role of BAX proapototic molecules in LE 
warrants further investigation. 
Based on our findings, the T cells and the cell signaling 
cascades  are  actively  targeting  not  only  the  BMZ,  but 
also skin adnexal structures; thus, the process may the 
result in dermal scarring and hair loss in some patients 
with  LE.  Additional  studies  are  necessary  to  further 
explore and define these pathophysiologic possibilities. 
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Figure 2. a. Positive IHC staining using anti-human BCL-2 antibody against some areas of an eccrine sweat glands (dark-
brown staining; red arrows), b. Positive anti-human-ZAP-70 antibody staining on a sebaceous gland. Please notice how 
some staining areas are accentuated along the BMZ of the gland, and some staining areas accentuated within the gland 
interior(brown staining; red arrows). c. ZAP-70 positive IHC staining in multiple patterns within and around a sebaceous 
gland. The patterns include dots inside and outside the gland, clustered dot staining, and along the gland BMZ (brown 
staining; red arrows). d. A Verhoeff elastin special stain confirms the extent of dermal scarring (red arrow). e, DIF positive 
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staining with FITC conjugated anti-human-IgG, in a punctate dot pattern around a hair follicle unit (yellow staining; red 
arrow). f, Positive DIF lupus band staining at the epidermal BMZ with FITC conjugated anti-human-complement/C3( faint 
yellow staining; red arrows). g Positive IHC staining with anti-human LAT antibody around a hair follicular unit (brown 
stain, red arrows). h. Positive DIF staining with FITC conjugated anti-human-Complement/C3 against some neurovascular 
structures (yellow/green staining; red arrows).  i. Positive IHC staining with anti-human COX-2 in a hair follicle and the 
eccrine gland coils (brown staining). j. Positive follicular and perifollicular IHC staining with anti-human myeloperoxidase 
(brown staining; red arrows).  k. Positive IHC staining with anti-human myeloid histiod antigen antibody within and near a 
sebaceous gland (brown staining; red arrows). l. Positive IHC staining with anti-human MUM-1 antibody around a hair 
follicle (brown staining; red arrow). 
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